ATE442364T1 - Kristalline form von linezolid - Google Patents

Kristalline form von linezolid

Info

Publication number
ATE442364T1
ATE442364T1 AT03769887T AT03769887T ATE442364T1 AT E442364 T1 ATE442364 T1 AT E442364T1 AT 03769887 T AT03769887 T AT 03769887T AT 03769887 T AT03769887 T AT 03769887T AT E442364 T1 ATE442364 T1 AT E442364T1
Authority
AT
Austria
Prior art keywords
crystalline form
linezolide
linezolid
preparation
relates
Prior art date
Application number
AT03769887T
Other languages
English (en)
Inventor
Rao Dodda Mohan
Reddy Pingili Krishna
Original Assignee
Symed Labs Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34430675&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE442364(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Symed Labs Ltd filed Critical Symed Labs Ltd
Application granted granted Critical
Publication of ATE442364T1 publication Critical patent/ATE442364T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/18—Oxygen atoms
    • C07D263/20—Oxygen atoms attached in position 2

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Photoreceptors In Electrophotography (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT03769887T 2003-10-16 2003-10-16 Kristalline form von linezolid ATE442364T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/IN2003/000336 WO2005035530A1 (en) 2003-10-16 2003-10-16 A novel crystalline form of linezolid

Publications (1)

Publication Number Publication Date
ATE442364T1 true ATE442364T1 (de) 2009-09-15

Family

ID=34430675

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03769887T ATE442364T1 (de) 2003-10-16 2003-10-16 Kristalline form von linezolid

Country Status (10)

Country Link
US (4) US7714128B2 (de)
EP (3) EP2902386B1 (de)
AT (1) ATE442364T1 (de)
AU (1) AU2003278592A1 (de)
DE (2) DE09163348T1 (de)
DK (1) DK1673370T3 (de)
ES (3) ES2803516T3 (de)
HU (1) HUE051230T2 (de)
PT (1) PT1673370E (de)
WO (1) WO2005035530A1 (de)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2803516T3 (es) 2003-10-16 2021-01-27 Symed Labs Ltd Una forma cristalina de linezolid
DE602004009344T2 (de) 2004-04-19 2008-07-10 Symed Labs Ltd., Hyderabad Neues verfahren zur herstellung von linezolid und verwandten verbindungen
JP2007504173A (ja) * 2004-06-29 2007-03-01 テバ ファーマシューティカル インダストリーズ リミティド リネゾリドのｉｖ型結晶
US20060111350A1 (en) * 2004-06-29 2006-05-25 Judith Aronhime Solid forms of linezolid and processes for preparation thereof
US7291614B2 (en) 2005-02-24 2007-11-06 Teva Pharmaceutical Industries Ltd. Processes for the preparation of linezolid intermediate
ES2309920T3 (es) * 2005-07-20 2008-12-16 Teva Pharmaceutical Industries Ltd. Composicion farmaceutica estable que comprende la forma iii de linezolid.
EP2033960A3 (de) 2007-09-04 2009-04-29 Dipharma Francis S.r.l. Kristalline Linezolidhydratform und Linezolidsalze
IT1390957B1 (it) * 2008-07-07 2011-10-27 Dipharma Francis Srl Sali di linezolid e loro uso nella preparazione di forme cristalline di linezolid
WO2009032294A2 (en) * 2007-09-06 2009-03-12 Teva Pharmaceutical Industries Ltd. Processes for the preparation of a linezolid intermediate, linezolid hydroxide
WO2009140466A2 (en) * 2008-05-14 2009-11-19 Dr. Reddy's Laboratories Ltd. Linezolid co-crystals
EP2493867A1 (de) 2009-10-28 2012-09-05 Synthon BV Verfahren zur herstellung einer kristallinen form von linezolid
WO2011050826A1 (en) * 2009-10-28 2011-05-05 Synthon B.V. Process for making crystalline form a of linezolid
WO2011077310A1 (en) 2009-12-26 2011-06-30 Alembic Limited Process for the preparation of linezolid
WO2012019632A1 (en) 2010-08-11 2012-02-16 Synthon B.V. Process for making linezolid
EP2603506A1 (de) 2010-08-11 2013-06-19 Synthon BV Verfahren zur herstellung von linezolid
EP2611799A4 (de) 2010-09-02 2014-01-29 Hetero Research Foundation Pharmazeutische zusammensetzungen aus linezolid
CN102070548B (zh) * 2011-01-13 2012-12-26 浙江新东港药业股份有限公司 一种晶型ⅰ型利奈唑胺的蒸发结晶工艺
WO2012114354A1 (en) 2011-02-24 2012-08-30 Lee Pharma Limited Anhydrous linezolid crystalline form-ii
EP2683696A1 (de) 2011-03-09 2014-01-15 Synthon BV Verfahren zur herstellung einer kristallinen form von linezolid
CN102766106A (zh) * 2011-05-03 2012-11-07 江苏豪森医药集团有限公司 利奈唑胺的新晶型及其制备方法
ITMI20111311A1 (it) * 2011-07-14 2013-01-15 Dipharma Francis Srl Sali di linezolid e loro uso nella preparazione di forme cristalline di linezolid
WO2013072923A1 (en) 2011-09-19 2013-05-23 Cadila Healthcare Limited Process for the preparation of crystalline linezolid
WO2013093751A1 (en) * 2011-12-24 2013-06-27 Alembic Pharmaceuticals Limited Packaging for linezolid
US20150025236A1 (en) * 2012-01-24 2015-01-22 Jubilant Life Sciences Limited Process for the preparation of stable crystalline form-i of linezolid, substantially free of residual solvent
WO2013120496A1 (en) 2012-02-14 2013-08-22 Pharmathen S.A. Process for the preparation of linezolid in crystalline form and salts thereof
WO2013190559A1 (en) * 2012-06-19 2013-12-27 Symed Labs Limited Improved processes for the preparation of linezolid crystalline form iii
US9492459B2 (en) * 2012-08-10 2016-11-15 Indoco Remedies Limited Pharmaceutical composition of linezolid
ES2603252T3 (es) 2012-11-09 2017-02-24 Synthon Bv Proceso para preparar linezolid
WO2014118809A1 (en) 2013-01-29 2014-08-07 Actavis Group Ptc Ehf. Pharmaceutical composition with linezolid
WO2015068121A1 (en) 2013-11-06 2015-05-14 Unimark Remedies Ltd. Process for preparation of crystalline form i of linezolid and its compositions
CN105254580B (zh) * 2014-04-22 2018-01-02 江苏豪森药业集团有限公司 利奈唑胺晶型的制备方法
WO2016113751A1 (en) * 2015-01-13 2016-07-21 Nosch Labs Private Limited Process for preparing crystalline linezolid form-iii
WO2018051360A1 (en) * 2016-09-16 2018-03-22 Lee Pharma Limited A novel process for the preparation of crystalline linezolid form-iii
CA3081449A1 (en) 2017-11-16 2019-05-23 Persica Pharmaceuticals Ltd. Linezolid formulations
CN110194750A (zh) * 2019-06-19 2019-09-03 四川美大康华康药业有限公司 一种利奈唑胺的制备方法及精制方法
WO2023062080A1 (en) 2021-10-12 2023-04-20 Persica Pharmaceuticals Ltd. Low back pain treatment

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US583870A (en) * 1897-06-01 Wrench
DE2810349A1 (de) 1978-03-10 1979-09-20 Kali Chemie Pharma Gmbh Verfahren zur herstellung von 3-hydroxy-6-phenyl-1,2,3,4-tetrahydro- 1,5-benzodiazocinen
FR2506769A2 (fr) 1978-06-09 1982-12-03 Delalande Sa Para-((cyano-5 n pentyl-1) phenyl)-3 methoxymethyl-5 oxazolidinone-2, son procede de preparation et ses applications en therapeutique
US4340606A (en) 1980-10-23 1982-07-20 E. I. Du Pont De Nemours And Company 3-(p-Alkylsulfonylphenyl)oxazolidinone derivatives as antibacterial agents
FR2608604B1 (fr) 1986-12-19 1989-04-28 Delalande Sa Derives 5-hydroxyethyles de l'oxazolidinone-2, leurs procedes de preparation et leurs applications en therapeutique
US5006528A (en) 1988-10-31 1991-04-09 Otsuka Pharmaceutical Co., Ltd. Carbostyril derivatives
DE9310451U1 (de) 1993-03-05 1994-06-30 Landis & Gyr Business Support Ag, Zug Steuer- bzw. Regeleinrichtung für Gas-Feuerungsautomaten von Heizungsanlagen
DE59306401D1 (de) 1993-03-11 1997-06-12 Landis & Gyr Tech Innovat Brennerregler
MY115155A (en) 1993-09-09 2003-04-30 Upjohn Co Substituted oxazine and thiazine oxazolidinone antimicrobials.
US5688792A (en) 1994-08-16 1997-11-18 Pharmacia & Upjohn Company Substituted oxazine and thiazine oxazolidinone antimicrobials
CZ200788A3 (cs) * 1996-04-11 2017-01-25 Pfizer Inc. Způsob přípravy 5-aminomethyl substituovaných oxazolidinonaminů
EP0890791A1 (de) 1997-07-11 1999-01-13 Electrowatt Technology Innovation AG Steuer- und Regelgerät für einen Brenner
NZ504372A (en) 1997-11-07 2002-12-20 Upjohn Co Process to produce N-[3-fluoro-4(4-morpholinyl)phenyl]-2-oxo-5-oxazolidinones
US6444813B2 (en) * 2000-02-02 2002-09-03 Pharmacia & Upjohn Company Linezolid-crystal form II
AR027261A1 (es) 2000-02-02 2003-03-19 Upjohn Co Linezolid forma cristalina ii
MY127336A (en) 2000-03-22 2006-11-30 Upjohn Co Container for linezolid iv solution
DE10037585A1 (de) * 2000-08-02 2002-02-14 Valeo Schalter & Sensoren Gmbh Rückstellvorrichtung für einen Blinkerschalter in Kraftfahrzeugen
HUP0302874A2 (hu) * 2000-08-14 2003-12-29 Teva Pharmaceutical Industries Ltd. Eljárás risperidon előállítására
CA2441854A1 (en) * 2001-02-05 2002-09-19 Pharmacia & Upjohn Company Composition for rectal delivery of an oxazolidinone antibacterial drug
CA2440600A1 (en) * 2001-04-20 2002-10-31 Pharmacia & Upjohn Company Process to prepare oxazolidinones
CN1155585C (zh) 2001-12-19 2004-06-30 中国医学科学院医药生物技术研究所 3,5－取代噁唑烷酮衍生物及其制备方法和应用
US6992219B2 (en) * 2002-08-09 2006-01-31 Cephalon France Modafinil polymorphic forms
ES2803516T3 (es) 2003-10-16 2021-01-27 Symed Labs Ltd Una forma cristalina de linezolid
DE602004009344T2 (de) 2004-04-19 2008-07-10 Symed Labs Ltd., Hyderabad Neues verfahren zur herstellung von linezolid und verwandten verbindungen
JP2007504173A (ja) * 2004-06-29 2007-03-01 テバ ファーマシューティカル インダストリーズ リミティド リネゾリドのｉｖ型結晶
ATE429423T1 (de) 2004-07-20 2009-05-15 Symed Labs Ltd Neue zwischenprodukte für linezolid und verwandte verbindungen

Also Published As

Publication number Publication date
US20080091011A1 (en) 2008-04-17
HUE051230T2 (hu) 2021-03-01
EP1673370B1 (de) 2009-09-09
WO2005035530A1 (en) 2005-04-21
ES2331001T3 (es) 2009-12-18
DE09163348T1 (de) 2010-01-07
US7718800B2 (en) 2010-05-18
DE60329237D1 (de) 2009-10-22
EP2902386B1 (de) 2020-04-08
AU2003278592A1 (en) 2005-04-27
US7714128B2 (en) 2010-05-11
US20060128703A1 (en) 2006-06-15
EP2902386A1 (de) 2015-08-05
ES2331454T1 (es) 2010-01-05
US7718799B2 (en) 2010-05-18
US7732597B2 (en) 2010-06-08
DK1673370T3 (da) 2009-12-07
EP1673370A1 (de) 2006-06-28
US20080090824A1 (en) 2008-04-17
PT1673370E (pt) 2009-11-05
EP2100884A1 (de) 2009-09-16
ES2803516T3 (es) 2021-01-27
US20080090820A1 (en) 2008-04-17

Similar Documents

Publication Publication Date Title
ATE442364T1 (de) Kristalline form von linezolid
DE60315368D1 (de) Korrektur des Weissabgleichs
CY2013036I1 (el) Συνθεσεις εμβολιου κατα της ναϊσσερια, που περιεχουν εναν συνδυασμο αντιγονων
BR0308452A (pt) composições farmacêuticas e métodos de preparação de composição farmacêutica
NO20071642L (no) N-Benzensulfonylsubstituerte anilino-pyrimidinanaloger
ECSP095220A (es) Derivados de n-fenil-2-pirimidin-amina
NO20062644L (no) DPP-IV inhibitorer
IS7806A (is) Ónæmisvaldandi samsetning
IS7716A (is) Hringlaga heterósambönd
DK1603524T3 (da) Enzymholdig oral sammensætning med forbedret stabilitet
IL159418A0 (en) Novel compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents
ATE428701T1 (de) Kristalline form von bisä(e)-7-ä4-(4-fluorphenyl)-6-isopropyl-2-
IL166483A0 (en) Pharmaceutical compositions containing ciclesonideand an antihistamine
DK1255754T3 (da) Linezolid-krystalform II
ATE364610T1 (de) Kristalline polymorphe form von irinotecan- hyrochlorid
DK1380121T3 (da) Fremgangsmåde til fremstilling af oxazolidinoner
ATE491814T1 (de) Herstellung von titanoxid
ATE444290T1 (de) Oxazolderivate von tetracyclinen
DE60107074D1 (de) Kristallin form ii von cabergolin
DE50213650D1 (de) Einrichtung zur Herstellung von Stapelpaketen
ATE527280T1 (de) Fluoreszentprotein und chromoprotein
DE60201084D1 (de) Herstellung von cyclischen esteroligomeren
DK1644385T3 (da) Siliciumforbindelser og deres anvendelse
DE60328456D1 (de) Eine kontinuierliche zellinie zur herstellung von impfstoffen
DE60236865D1 (de) Kosmetische zubereitung enthaltend einen extrakt von den nebenwurzeln des bergginsengs

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1673370

Country of ref document: EP